P

Inventor

SUMNER-SMITH MARTIN

CA14 patents
⚠️ This page may combine multiple inventors who share the name “SUMNER-SMITH MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALLELIX BIOPHARMA

5 patents
US5789379AAug 4, 1998

Glucagon-like peptide-2 analogs

ALLELIX BIOPHARMA143 citations97
US5674849AOct 7, 1997

Anti-viral compositions

ALLELIX BIOPHARMA27 citations91
US5633230AMay 27, 1997

Treatment of cytomegalovirus infection

ALLELIX BIOPHARMA41 citations91
US5831001ANov 3, 1998

Treatment of herpesvirus infection

ALLELIX BIOPHARMA25 citations90
US5646120AJul 8, 1997

Peptide-based inhibitors of HIV replication

ALLELIX BIOPHARMA40 citations90

ONTARIO INC 1149336

2 patents
US5994500ANov 30, 1999

Antagonists of intestinotrophic GLP-2 peptides

ONTARIO INC 114933649 citations95
US6489295B1Dec 3, 2002

Antagonists of intestinotrophic GLP-2 peptides

ONTARIO INC 114933628 citations92

JENKINS PAUL THOMAS

2 patents
US8464206B2Jun 11, 2013

Method and system for managing enterprise content

JENKINS PAUL THOMAS26 citations86
US8880461B2Nov 4, 2014

Method and system for managing enterprise content

JENKINS PAUL THOMAS10 citations77

NPS PHARMA INC

2 patents
US8846625B2Sep 30, 2014

Glucagon-like peptide-2 analogs

NPS PHARMA INC0 citations51
US7781401B2Aug 24, 2010

Glucagon-like peptide-2 analogs

NPS PHARMA INC0 citations51

NPS ALLELIX CORP

1 patent
US6184201B1Feb 6, 2001

Intestinotrophic glucagon-like peptide-2 analogs

NPS ALLELIX CORP138 citations98

ALLEX BIOPHARMACEUTICALS INC

1 patent
US5789531AAug 4, 1998

Peptide-based inhibitors of HIV replication

ALLEX BIOPHARMACEUTICALS INC22 citations87

DRUCKER DANIEL J

1 patent
US8933039B2Jan 13, 2015

Glucagon-like peptide-2 analogs

DRUCKER DANIEL J0 citations50